CodeMap® Compliance Briefing: April 7, 2023
Editor's Welcome:
Medicare's Molecular Diagnostics (MolDX) program was developed in 2011. Through the years there have been many changes and advancements. This week our friends at Laboratory Economics talked with Gabriel Bien-Wilner MD, PHD, chief medical officer at MolDx, regarding his work at the program and the latest updates.
Sincerely,
Lara Tavolino
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.
| 